December 12, 2024 10:38 AM EST
Manufacturing

Dai­ichi's $150M build in Chi­na; Bio­Marin re­veals €60M Irish ex­pan­sion

Anna Brown

News Reporter

Wel­come to End­points News’ man­u­fac­tur­ing briefs, where we bring you es­sen­tial news on new builds, col­lab­o­ra­tions, re­calls and more.

Dai­ichi Sankyo is

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Keros halts parts of Phase 2 PAH tri­al due to safe­ty, stock tanks 70%

In­side Iso­mor­phic Labs: Demis Has­s­abis’ lab-free vi­sion for biotech’s AI fu­ture

Lon­za looks to de­part cap­sule and health in­gre­di­ents as it un­der­goes re­struc­ture

The brain is Eli Lil­ly's next tar­get for its obe­si­ty meds

Cor­cept’s ALS drug fails to im­prove func­tion in Phase 2 study

sponsored

The key to faster, more im­pact­ful re­search? Put pa­tients in the dri­ver’s seat

A service from the Financial Times